Insider selling
Traded Nov 16 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 2 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider selling
Traded Nov 16 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade
Entergy's Reporting person sold $269K of Entergy shares. The filing does not indicate a pre-arranged trading plan.
Lately at Entergy: it reported its results on Nov 2.
Insider buying
First insider buy since Oct 2024Traded Nov 13 · filed 3 days later
Since the trade +13.1% · S&P 500 −8.6% · to Nov 20
Bought at the 52-week low, RSI 24, 38% under its 200-day average, 35 points behind the S&P 500 over 3 months
The CEO of Cormedix paid $391K out of pocket for Cormedix shares. 3 other people at Cormedix bought some too, in the same month. It was the first purchase in over a year.
Lately at Cormedix: the stock rose 13% in one session on Nov 19; it reported its results on Nov 12; the stock is down 32% in 30 days.
Insider buying
Largest insider buy since 2014Traded Nov 13 · filed 3 days later
Since the trade −10.8% · S&P 500 −8.6% · to Nov 20
Bought 46% below the 52-week high, RSI 46, 4% under its 200-day average
The CEO of HubSpot paid $5M out of pocket for HubSpot shares. Shares held went up 39% with this purchase.
Lately at HubSpot: it changed a top executive or board member on Nov 12; the stock is down 22% in 30 days.
Insider buying
Open-market purchases, traded Nov 16, 2026. Each amount is that person's own.
Lately at Forgent Power Solutions: the stock fell 19% in one session on Nov 5 with press coverage; it reported its results on Nov 12; the stock is down 43% in 30 days.
Traded Nov 12 – Nov 16, 2026 · largest single transaction ~$397K
Lately at Neostellar Capital: it reported its results on Nov 3; the stock is down 22% in 30 days; insiders made 7 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 13, 2026~$397K · 65K sh @ $6.10
DetailsOfficial recordNov 16, 2026~$202K · 35K sh @ $5.78
DetailsOfficial recordNov 12, 2026~$395K · 65K sh @ $6.08
DetailsOfficial recordInsider buying
5 insiders in a week, 4th time since 2008Traded Nov 12 · filed 4 days later
Since the trade +3.5% · S&P 500 −8.9% · to Nov 20
Bought within 1% of the 52-week low, RSI 13, 39% under its 200-day average, 47 points behind the S&P 500 over 3 months
A Futurefuel director paid $284K out of pocket for Futurefuel shares. 4 other people at Futurefuel bought some too, in the same month. It was the first purchase in over a year.
Lately at Futurefuel: the stock fell 38% in one session on Nov 10 around a company release; it reported its results on Nov 9; the stock is down 47% in 30 days.
Insider buying
3 insiders in a week, 6th time since 2006Traded Nov 16 · filed the same day
Since the trade −2.9% · S&P 500 −6.8% · to Nov 20
Bought at the 52-week low, RSI 34, 38% under its 200-day average, 21 points behind the S&P 500 over 3 months
The CFO of Lineage Cell Therapeutics paid $17K out of pocket for Lineage Cell Therapeutics shares. 4 other people at Lineage Cell Therapeutics bought some too, in the same month. It was the first purchase in 24 months.
Lately at Lineage Cell Therapeutics: it completed buying or selling a business or assets on Nov 12; the stock is down 19% in 30 days; insiders made 5 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Open-market purchases, traded Nov 13, 2026. Each amount is that person's own.
Lately at ADI Global Distribution: the stock fell 50% in one session on Nov 12 around a company release; it reported its results on Nov 12; the stock is down 46% in 30 days.
Insider buying
Their first buy on recordTraded Nov 12 · filed 4 days later
Since the trade −6.6% · S&P 500 −8.9% · to Nov 20
Bought 48% below the 52-week high, RSI 27, 28% under its 200-day average, 22 points behind the S&P 500 over 3 months
An Amdocs director paid $215K out of pocket for Amdocs shares. 7 other people at Amdocs bought some too, in the same month. Shares held went up 25% with this purchase.
Lately at Amdocs: the stock fell 30% in one session on Nov 4 with press coverage; the stock is down 33% in 30 days; insiders made 7 purchases ($10K+) and 2 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
3 insiders in a week, 6th time since 2006Traded Nov 13 · filed 3 days later
Since the trade −8.7% · S&P 500 −8.6% · to Nov 20
Bought within 2% of the 52-week low, RSI 24, 19% under its 200-day average, 20 points behind the S&P 500 over 3 months
The CEO of Gladstone Commercial paid $100K out of pocket for Gladstone Commercial shares. 2 other people at Gladstone Commercial bought some too, in the same month. Shares held went up 22% with this purchase.
Lately at Gladstone Commercial: it reported its results on Nov 3; the stock is down 22% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 11 · filed 5 days later
Since the trade −14.8% · S&P 500 −9.2% · to Nov 20
A Csquare director paid $172K out of pocket for Csquare shares. 3 other people at Csquare bought some too, in the same month. Shares held went up 100% with this purchase.
Lately at Csquare: the stock rose 15% in one session on Nov 10 around a company release; it reported its results on Nov 9; the stock is down 14% in 30 days.
Insider buying
First insider buy since Nov 2023Traded Nov 13 · filed 3 days later
Since the trade −16.3% · S&P 500 −8.6% · to Nov 20
Bought within 3% of the 52-week low, RSI 25, 35% under its 200-day average, 31 points behind the S&P 500 over 3 months
The CEO of Corteva paid $300K out of pocket for Corteva shares. 1 other person at Corteva bought some too, in the same month. Shares held went up 21% with this purchase.
Lately at Corteva: the stock fell 24% in one session on Nov 12 around a company release; it reported its results on Nov 12; the stock is down 38% in 30 days.
Insider buying
Traded Nov 12 · filed 4 days later
Since the trade −4.1% · S&P 500 −8.9% · to Nov 20
Bought at the 52-week low, RSI 21, 23% under its 200-day average, 17 points behind the S&P 500 over 3 months
Pampa Energy's Vicepresident paid $1.26M out of pocket for Pampa Energy shares. 3 other people at Pampa Energy bought some too, in the same month.
Lately at Pampa Energy: the stock is down 22% in 30 days; insiders made 24 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
5 insiders in a week, 2nd time since 2006Traded Nov 12 · filed 4 days later
Since the trade −10.5% · S&P 500 −8.9% · to Nov 20
Bought 85% below the 52-week high, RSI 24, 76% under its 200-day average, 70 points behind the S&P 500 over 3 months
A Perspective Therapeutics director paid $20K out of pocket for Perspective Therapeutics shares. 4 other people at Perspective Therapeutics bought some too, in the same month. It was the first purchase in 20 months.
Lately at Perspective Therapeutics: the stock fell 29% in one session on Oct 23 around a company release; it reported its results on Nov 9; the stock is down 67% in 30 days.